Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria

Allergy. 2011 Feb;66(2):303-5. doi: 10.1111/j.1398-9995.2010.02472.x. Epub 2010 Sep 7.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Chronic Disease
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Middle Aged
  • Omalizumab
  • Treatment Outcome
  • Urticaria / drug therapy*
  • Young Adult

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Omalizumab